Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital ...Middle East

PR Newswire - Economy
Oncolytics Biotech® Funds Pelareoreps Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital

SAN DIEGO and CALGARY, AB, April 10, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni), an institutional...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital )

    Also on site :



    Latest News